Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03220022Phase 1Active Not Recruiting
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
AIDS-Related LymphomaAnn Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell Lymphoma+1 more
PrincipalinvestigatorStart date: 2018-03-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ariela Noy, MD

Memorial Sloan Kettering Cancer Center

Related
6 trials

Shared therapeutic areas:

Ann Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Yucai Wang, M.D., Ph.D.

Mayo Clinic in Rochester

Related
1 trials

Shared therapeutic areas:

Ann Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma
Similarity Score23%

Grzegorz S Nowakowski

ECOG-ACRIN Cancer Research Group

Related
1 trials

Shared therapeutic areas:

Ann Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Juan C Ramos

AIDS Malignancy Consortium

Related
1 trials

Shared therapeutic areas:

Ann Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Elizabeth A Brem

SWOG Cancer Research Network

Related
1 trials

Shared therapeutic areas:

Ann Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

David A. Wohl

Univ of North Carolina

Related
1 trials

Shared therapeutic areas:

Lymphoma, AIDS-Related

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Francois Boue, MD

Service de Medecine Interne Hopital A Beclere Clamart France

Related
1 trials

Shared therapeutic areas:

Lymphoma, AIDS-Related
Similarity Score8%

Christopher Melani, M.D.

National Cancer Institute (NCI)

Related
1 trials

Shared therapeutic areas:

Lymphoma, AIDS-Related

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Dominique Costagliola

Inserm U 720

Related
4 trials

Shared therapeutic areas:

Lymphoma, AIDS-Related
Similarity Score8%

Nicolaus Kroeger

University Medical Center Hamburg-Eppendorf, Department for Stem Cell Transplantation

Related
1 trials

Shared therapeutic areas:

Lymphoma, AIDS-Related
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03220022Phase 1PrincipalInvestigator

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

AIDS-Related LymphomaAnn Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell Lymphoma+1 more
Active Not Recruiting

All 1 trials loaded